Optics: measuring and testing – By dispersed light spectroscopy
Patent
1998-05-06
2000-08-29
Kim, Robert
Optics: measuring and testing
By dispersed light spectroscopy
356302, 356303, 356319, G01J 300
Patent
active
061116394
ABSTRACT:
A method and apparatus for counteracting adverse drug events (ADE's) which are caused by the administration of intravenous medications of incorrect types, concentrations or dosages, and which may result in morbidity and even mortality to recipient patients. A container, preferably in the nature of a transparent plastic bag employed for intravenous administrations, contains the requisite infusion at a prescribed volume, adding a specified amount of prescribed medication possessing a predefined amount of a coloring material, such as a vegetable dye, to the volume of infusion material or liquid in order to form a prescribed concentration of medication, with the coloring material defining a specific type of medication. Analyzing of the concentration of medication is effected through the utilization of spectrophotometric equipment, and to resultingly obtain a real medication concentration value. Thereafter, a comparison is carried out between the real or actual and the prescribed medication concentration values, and an indicator, such as a label or the like, is generated for placement on the intravenous container which is indicative of the type and verified concentration of the medication in the infusion. This procedure, in effect, by being implemented at the pharmacy level, provides for medication and concentration verification prior to administering the medication intravenously to a patient, and by verifying the presence of the indicator on the intravenous (IV) container, or by using a spectrophotometer at a nurse station in order to again verify the medication and its concentration as a check or safeguard preceding administration thereof to the patient.
REFERENCES:
patent: 5229362 (1993-07-01), Kirst et al.
patent: 5267178 (1993-11-01), Berner
patent: 5298428 (1994-03-01), O'Rourke et al.
patent: 5400138 (1995-03-01), Peterson et al.
patent: 5468224 (1995-11-01), Souryal
patent: 5510621 (1996-04-01), Goldman
patent: 5563031 (1996-10-01), Yu
Kim Robert
Ratliff Reginald A.
LandOfFree
Method and apparatus for countering adverse drug events does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for countering adverse drug events, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for countering adverse drug events will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1254730